MSR1 and infection: Mechanistically, treatment with recombinant NPFF during infection reduced the frequency of IFNγ+ and ROS+ neutrophils but increased the proportion of CD204+ neutrophils and led to a decreased ability by NPFF-conditioned neutrophils to clear bacteria.